Universal Beteiligungs und Servicegesellschaft mbH Has $311,000 Position in Ingevity Corporation $NGVT

Universal Beteiligungs und Servicegesellschaft mbH lowered its stake in shares of Ingevity Corporation (NYSE:NGVTFree Report) by 79.5% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 7,210 shares of the company’s stock after selling 27,915 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Ingevity were worth $311,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of NGVT. Wellington Management Group LLP boosted its holdings in shares of Ingevity by 2.6% during the 1st quarter. Wellington Management Group LLP now owns 2,299,312 shares of the company’s stock worth $91,030,000 after buying an additional 59,342 shares during the period. American Century Companies Inc. raised its holdings in Ingevity by 1.3% in the 1st quarter. American Century Companies Inc. now owns 1,476,748 shares of the company’s stock worth $58,464,000 after acquiring an additional 19,383 shares during the period. Millennium Management LLC lifted its position in Ingevity by 8.0% during the 1st quarter. Millennium Management LLC now owns 1,226,189 shares of the company’s stock worth $48,545,000 after acquiring an additional 90,958 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in Ingevity by 8.6% during the first quarter. Charles Schwab Investment Management Inc. now owns 701,755 shares of the company’s stock valued at $27,782,000 after acquiring an additional 55,488 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in shares of Ingevity by 311.8% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 600,380 shares of the company’s stock valued at $23,769,000 after purchasing an additional 454,579 shares during the last quarter. Institutional investors own 91.59% of the company’s stock.

Ingevity Stock Up 0.1%

NGVT stock opened at $52.23 on Friday. Ingevity Corporation has a twelve month low of $28.49 and a twelve month high of $60.77. The company has a quick ratio of 0.80, a current ratio of 1.36 and a debt-to-equity ratio of 10.24. The company has a market cap of $1.88 billion, a PE ratio of -8.78 and a beta of 1.45. The business’s 50-day simple moving average is $53.10 and its 200 day simple moving average is $49.87.

Ingevity (NYSE:NGVTGet Free Report) last announced its quarterly earnings data on Friday, March 24th. The company reported $0.78 EPS for the quarter. Ingevity had a positive return on equity of 84.92% and a negative net margin of 16.35%.The company had revenue of $336.00 million during the quarter. On average, research analysts anticipate that Ingevity Corporation will post 4.45 earnings per share for the current year.

Analyst Ratings Changes

Several research firms recently weighed in on NGVT. BMO Capital Markets boosted their price objective on Ingevity from $62.00 to $68.00 and gave the stock an “outperform” rating in a research report on Friday, September 5th. Wells Fargo & Company lifted their price target on Ingevity from $52.00 to $55.00 and gave the stock an “equal weight” rating in a research report on Wednesday, November 12th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Ingevity in a report on Wednesday, October 8th. Finally, Wall Street Zen raised Ingevity from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 9th. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $61.50.

View Our Latest Stock Report on Ingevity

Ingevity Company Profile

(Free Report)

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.

Further Reading

Institutional Ownership by Quarter for Ingevity (NYSE:NGVT)

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.